Compare Mirae Asset Healthcare Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹99 | ₹500 |
Expense Ratio | 1.93 | 2.27 |
NAV | ₹37.42 | ₹275.66 |
Fund Started | 11 Jun 2018 | 01 Aug 2005 |
Fund Size | ₹2770.84 Cr | ₹1101.63 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹99
₹500
Expense Ratio
1.93
2.27
NAV
₹37.42
₹275.66
Fund Started
11 Jun 2018
01 Aug 2005
Fund Size
₹2770.84 Cr
₹1101.63 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 1% if redeemed within 30 days.
1 Year | 0.28% | -1.05% |
3 Year | 20.67% | 22.86% |
5 Year | 14.60% | 14.03% |
1 Year
0.28%
-1.05%
3 Year
20.67%
22.86%
5 Year
14.60%
14.03%
Equity | 99.46% | 99.40% |
Cash | 0.54% | 0.59% |
Equity
99.46%
99.40%
Cash
0.54%
0.59%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.44% |
Divi's Laboratories Ltd. | 8.57% |
Glenmark Pharmaceuticals Ltd. | 6.91% |
Apollo Hospitals Enterprise Ltd. | 5.80% |
Cipla Ltd. | 5.55% |
Lupin Ltd. | 5.23% |
Dr. Reddy's Laboratories Ltd. | 4.34% |
Aurobindo Pharma Ltd. | 4.24% |
Fortis Healthcare Ltd. | 4.22% |
Ipca Laboratories Ltd. | 3.46% |
Sun Pharmaceutical Industries Ltd. | 9.37% |
Ajanta Pharma Ltd. | 7.16% |
Lupin Ltd. | 5.65% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Gland Pharma Ltd. | 3.60% |
Procter & Gamble Health Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.46% |
Cipla Ltd. | 3.43% |
Alkem Laboratories Ltd. | 3.40% |
Apollo Hospitals Enterprise Ltd. | 3.39% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 11 Jun 2018 | 01 Aug 2005 |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
11 Jun 2018
01 Aug 2005